CNBX Pharmaceuticals CNBX Growth Metrics (2011-2026)

OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT
Reported Financials

CNBX Pharmaceuticals Quarterly Growth Metrics

Periods 58 quarters
Latest May 2026

CNBX Pharmaceuticals reported asset growth of -31.27% for the quarter ended May 2026. These growth metrics cover 58 quarters of results from Aug 2011 through May 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Aug2011 Nov2011 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026 May2026
Growth Ratios
Assets Growth (1y)
38.73%24.82%-77.09%-74.60%-73.65%-71.25%-59.39%-31.45%-38.48%-36.44%-64.52%-87.91%-93.71%-94.24%-69.09%-76.74%-41.25%-49.96%-70.59%-31.27%
Assets Growth (3y)
-1.12%-39.31%-60.42%-63.45%-62.34%-54.48%-49.42%-50.71%-39.19%-38.90%-67.92%-72.39%-78.32%-78.09%-64.56%-73.19%-71.67%-73.64%-68.17%-73.16%
Assets Growth (5y)
164.65%49.60%13.97%-22.54%-25.93%-27.59%-34.12%-26.85%-30.97%-47.25%-61.08%-66.78%-70.96%-67.82%-57.31%-67.98%-61.64%-63.40%-68.71%-67.98%
Assets (QoQ)
-19.02%-31.14%-46.33%-15.12%-16.01%-24.86%-24.19%43.28%-24.62%-22.37%-57.69%-51.18%-60.78%-28.92%127.09%-63.26%-0.96%-39.46%33.48%-14.12%
Capital Expenditures Growth (1y)Capex Growth (1y)
-45.60%
Capital Expenditures Growth (3y)Capex Growth (3y)
-81.13%-65.55%8.24%
Capital Expenditures Growth (5y)Capex Growth (5y)
-49.47%-56.45%
Capital Expenditures (QoQ)Capex (QoQ)
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
78.30%327.33%-82.64%-95.11%-91.52%-97.25%-79.39%-54.14%10.37%278.00%-22.21%66.26%-79.63%-78.76%22.97%-81.41%-42.80%-55.57%-73.39%-30.49%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-0.17%-50.74%-64.48%-42.00%-23.84%-59.26%-56.67%-50.21%-44.95%-23.73%-69.69%-66.59%-73.29%-71.96%-41.80%-47.86%-49.53%-29.09%-36.62%-40.10%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
135.53%23.10%-16.40%-50.35%-39.02%-62.44%-55.91%-54.30%-37.80%-58.43%-62.73%-31.69%-36.99%-44.16%-39.99%-47.96%-54.53%-46.99%-60.93%-65.60%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-29.56%-43.28%-70.55%-58.44%22.06%-81.62%121.06%-7.53%193.76%-37.05%-54.51%97.64%-64.01%-34.36%163.42%-70.12%10.72%-49.02%57.78%-21.94%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
45.60%-19.03%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
92.66%-65.76%-70.79%-8.24%-68.60%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
22.35%15.31%75.28%15.18%15.15%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
1,772.24%373.37%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
18.51%-1.17%21.01%39.08%74.30%84.00%96.66%95.05%113.72%25.09%-571.26%101.21%-335.17%45.61%58.47%-23,219.56%40.84%-21.32%40.87%8.37%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
2.18%3.50%9.13%22.89%44.37%49.88%70.52%68.16%26.59%50.51%43.84%26.00%56.39%59.76%54.67%48.25%42.42%20.93%-18.13%-36.87%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-53.01%-32.47%-27.03%-12.81%15.32%26.69%46.79%47.49%15.25%35.96%29.98%14.87%43.90%44.79%41.02%38.17%47.47%39.66%46.58%40.06%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
5.57%-3.05%7.47%32.34%60.17%35.85%80.68%-0.32%210.36%-450.18%-73.15%100.18%-21,544.44%19.01%-32.21%-0.69%45.13%-66.08%35.56%-56.03%
EBITDA Margin Growth (1y)
0.13M
EBITDA Margin Growth (3y)
4.39M3.32M2.81M
EBITDA Margin Growth (5y)
3.62M2.83M2.23M1.81M3.60M
EBITDA Margin (QoQ)
-0.01M-0.00M-0.03M
EBIT Growth (1y)
11.09%-68.30%-9.34%6.10%19.78%68.77%65.76%72.74%66.24%50.43%17.43%12.02%67.47%78.57%68.64%73.48%-146.95%-73.74%-12.70%-303.08%
EBIT Growth (3y)
6.03%-19.65%6.59%6.61%21.26%24.81%33.92%36.95%37.79%36.13%32.39%39.16%55.50%67.87%55.41%60.09%35.27%43.07%33.67%2.03%
EBIT Growth (5y)
-55.02%-60.93%-30.55%-6.07%15.12%8.37%31.86%27.29%25.81%23.32%25.44%27.86%44.30%46.18%40.48%43.32%28.01%37.29%35.78%24.79%
EBIT Margin Growth (1y)
0.14M
EBIT Margin Growth (3y)
4.60M3.66M3.02M
EBIT Margin Growth (5y)
3.62M2.88M2.41M1.94M3.81M
EBIT Margin (QoQ)
-0.01M-0.00M-0.03M
EBIT (QoQ)
11.82%-86.20%34.23%13.04%24.67%27.50%27.91%30.77%6.69%-6.44%-20.09%26.23%65.50%29.88%-75.76%37.63%-221.28%50.67%-14.00%-123.08%
EBT Growth (1y)
11.09%-68.30%-9.34%6.10%19.78%68.77%65.76%72.74%66.24%50.43%17.43%12.02%67.47%78.57%68.64%73.48%-146.95%-73.74%-12.70%-303.08%
EBT Growth (3y)
6.03%-19.65%6.59%6.61%21.26%24.81%33.92%36.95%37.79%36.13%32.39%39.16%55.50%67.87%55.41%60.09%35.27%43.07%33.67%2.03%
EBT Growth (5y)
-55.02%-60.93%-10.75%-20.94%15.12%8.37%31.31%27.63%25.81%23.32%25.44%27.86%44.30%46.18%40.48%43.32%28.01%37.29%35.78%24.79%
EBT Margin Growth (1y)
0.14M
EBT Margin Growth (3y)
4.60M3.66M3.02M
EBT Margin Growth (5y)
3.62M2.94M2.41M1.94M3.81M
EBT Margin (QoQ)
-0.01M-0.00M-0.03M
EBT (QoQ)
11.82%-86.20%34.23%13.04%24.67%27.50%27.91%30.77%6.69%-6.44%-20.09%26.23%65.50%29.88%-75.76%37.63%-221.28%50.67%-14.00%-123.08%
EPS (Basic) Growth (1y)
9.58%-88.63%-112.93%-5,548.68%-7,878.94%-3,010.36%-15,778.45%96.97%83.43%97.74%99.21%74.85%96.92%82.83%79.30%66.61%17.32%85.95%97.82%88.96%
EPS (Basic) Growth (3y)
6.85%-19.70%-31.96%-414.14%-234.12%-94.78%-492.08%-45.91%-128.63%-9.89%-38.49%24.46%25.87%50.57%36.32%86.34%83.84%91.83%96.72%78.99%
EPS (Basic) Growth (5y)
-49.27%-46.46%-17.05%-204.08%-108.35%-129.20%-150.31%-18.21%-60.60%-3.82%-18.85%-0.73%28.23%50.84%19.52%23.56%21.17%49.76%58.73%56.32%
EPS (Basic) (QoQ)
49.52%-85.90%7.90%-6,435.27%28.69%27.53%-370.19%98.75%-289.32%90.11%-63.32%60.02%52.30%44.87%-96.92%35.51%-18.10%90.63%69.48%-226.93%
EPS (Diluted) Growth (1y)
52.93%-7,878.94%-2,717.61%-32.32%96.97%83.43%97.74%99.21%74.85%96.92%82.83%79.30%66.61%17.32%85.95%97.82%91.66%
EPS (Diluted) Growth (3y)
84.69%25.87%52.17%87.09%86.34%83.84%91.83%96.72%80.87%
EPS (Diluted) Growth (5y)
84.15%
EPS (Diluted) (QoQ)
99.58%-105.22%-9,912.11%45.54%28.69%27.53%-370.19%98.75%-289.32%90.11%-63.32%60.02%52.30%44.87%-96.92%35.51%-18.10%90.63%69.48%-146.84%
FCF Margin Growth (1y)
0.05M
FCF Margin Growth (3y)
4.31M3.37M3.24M
FCF Margin Growth (5y)
1.27M1.91M2.78M2.24M3.33M
FCF Margin (QoQ)
0.00M-0.01M-0.02M
Free Cash Flow Growth (1y)FCF Growth (1y)
18.51%-1.09%21.01%39.08%74.11%84.02%96.66%95.05%113.62%23.85%-571.26%101.21%-335.17%46.50%58.47%-23,219.56%40.84%-21.32%40.87%8.37%
Free Cash Flow Growth (3y)FCF Growth (3y)
10.87%6.90%10.72%25.04%44.82%50.09%70.59%69.20%26.59%50.26%43.84%26.00%56.39%59.77%54.67%48.25%42.56%20.93%-18.13%-36.87%
Free Cash Flow Growth (5y)FCF Growth (5y)
-53.01%-32.50%-26.77%-4.95%16.81%26.83%55.60%49.46%15.16%37.13%30.72%14.87%44.26%44.93%41.10%39.40%47.47%39.68%46.58%40.06%
Free Cash Flow (QoQ)FCF (QoQ)
5.57%-3.13%7.55%32.34%59.86%36.33%80.68%-0.32%210.36%-456.01%-70.31%100.18%-21,544.44%19.01%-32.21%-0.69%45.13%-66.08%35.56%-56.03%
Gross Margin Growth (1y)
Gross Margin (QoQ)
Gross Profit Growth (1y)
Gross Profit (QoQ)
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
Net Cash Flow Growth (1y)NCF Growth (1y)
-238.53%-1.09%-148.23%-121.35%104.48%84.02%104.71%97.34%227.88%49.90%-499.26%2,773.26%-154.93%81.11%127.14%-133.31%103.11%18.39%-84.29%91.67%
Net Cash Flow Growth (3y)NCF Growth (3y)
10.87%-28.38%26.76%69.29%28.36%-56.01%-53.94%74.97%-41.16%56.74%-27.87%-46.67%56.77%75.27%27.06%38.15%-61.72%57.41%-44.58%9.49%
Net Cash Flow Growth (5y)NCF Growth (5y)
-53.01%-33.98%-31.41%-15.46%-31.84%27.52%25.31%64.62%16.04%-14.98%40.60%15.11%27.05%-16.76%-36.18%32.55%-67.76%58.39%-67.08%-14.92%
Net Cash Flow (QoQ)NCF (QoQ)
-191.79%-3.13%7.55%75.60%119.27%-467.63%127.26%-113.76%2,478.23%-156.17%-117.27%192.11%-148.87%80.68%412.17%-213.03%104.57%-606.36%160.08%-159.92%
Net Income Growth (1y)
11.09%-68.30%-9.34%6.10%19.78%68.77%65.76%72.74%66.24%50.43%17.43%12.02%67.47%78.57%68.64%73.48%-146.95%-73.74%-12.70%-303.08%
Net Income Growth (3y)
6.03%-19.65%6.59%6.61%21.26%24.81%33.92%36.95%37.79%36.13%32.39%39.16%55.50%67.87%55.41%60.09%35.27%43.07%33.67%2.03%
Net Income Growth (5y)
-54.15%-60.93%-10.75%-20.94%15.39%8.37%31.31%27.63%25.81%23.32%25.44%27.86%44.30%46.18%40.48%43.32%28.01%37.29%35.78%24.79%
Net Income (QoQ)
11.82%-86.20%34.23%13.04%24.67%27.50%27.91%30.77%6.69%-6.44%-20.09%26.23%65.50%29.88%-75.76%37.63%-221.28%50.67%-14.00%-123.08%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
6.91%-102.06%-131.67%48.51%29.57%72.97%-111.83%77.31%-19.56%50.09%87.60%15.55%89.44%80.76%78.56%54.28%-147.77%-231.04%36.81%-158.12%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
2.38%-26.35%-32.61%-7.58%29.91%58.87%-44.61%40.26%7.80%35.16%15.26%53.79%55.36%70.39%61.67%55.58%32.11%31.75%74.39%0.11%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-58.30%-55.18%-23.10%-22.67%15.34%7.82%-9.92%29.24%4.77%22.92%-15.86%24.92%46.58%63.28%39.60%39.31%27.15%29.54%39.29%34.95%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
48.54%-94.23%6.36%44.98%29.63%25.44%-633.73%94.11%-270.78%68.87%-82.31%59.86%53.62%43.30%-103.16%14.42%-151.33%24.24%61.22%-249.60%
Net Margin Growth (1y)
0.10M
Net Margin Growth (3y)
6.61M3.84M3.26M
Net Margin Growth (5y)
3.68M2.94M2.42M1.96M-16.16M
Net Margin (QoQ)
-0.05M0.04M-0.06M
Operating Income Growth (1y)Op. Inc Growth (1y)
11.09%-68.30%-9.34%6.10%19.78%68.77%65.76%72.74%66.24%50.43%17.43%12.02%67.47%78.57%68.64%73.48%-146.95%-73.74%-12.70%-303.08%
Operating Income Growth (3y)Op. Inc Growth (3y)
6.03%-19.65%6.59%6.61%21.26%24.81%33.92%36.95%37.79%36.13%32.39%39.16%55.50%67.87%55.41%60.09%35.27%43.07%33.67%2.03%
Operating Income Growth (5y)Op. Inc Growth (5y)
-55.02%-60.93%-30.55%-6.07%15.12%8.37%31.86%27.29%25.81%23.32%25.44%27.86%44.30%46.18%40.48%43.32%28.01%37.29%35.78%24.79%
Operating Income (QoQ)Op. Inc (QoQ)
11.82%-86.20%34.23%13.04%24.67%27.50%27.91%30.77%6.69%-6.44%-20.09%26.23%65.50%29.88%-75.76%37.63%-221.28%50.67%-14.00%-123.08%
Operating Margin Growth (1y)
0.14M
Operating Margin Growth (3y)
4.60M3.66M3.02M
Operating Margin Growth (5y)
3.62M2.88M2.41M1.94M3.81M
Operating Margin (QoQ)
-0.01M-0.00M-0.03M
Profit After Tax Growth (1y)PAT Growth (1y)
11.09%-68.30%-9.34%6.10%19.78%68.77%65.76%72.74%66.24%50.43%17.43%12.02%67.47%78.57%68.64%73.48%-146.95%-73.74%-12.70%-303.08%
Profit After Tax Growth (3y)PAT Growth (3y)
6.03%-19.65%6.59%6.61%21.26%24.81%33.92%36.95%37.79%36.13%32.39%39.16%55.50%67.87%55.41%60.09%35.27%43.07%33.67%2.03%
Profit After Tax Growth (5y)PAT Growth (5y)
-55.02%-60.93%-10.75%-20.94%15.12%8.37%31.31%27.63%25.81%23.32%25.44%27.86%44.30%46.18%40.48%43.32%28.01%37.29%35.78%24.79%
Profit After Tax (QoQ)PAT (QoQ)
11.82%-86.20%34.23%13.04%24.67%27.50%27.91%30.77%6.69%-6.44%-20.09%26.23%65.50%29.88%-75.76%37.63%-221.28%50.67%-14.00%-123.08%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-25.49%-26.63%-27.85%-29.07%-32.06%-33.47%-34.71%-36.36%-37.10%-39.92%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
-12.94%-16.17%-18.37%-21.52%-24.18%-25.72%-27.14%-29.94%-31.72%-33.56%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
230.80%237.30%191.15%40.46%29.40%26.88%-13.86%-17.69%-22.37%-25.12%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-7.35%-7.98%-8.55%-9.03%-11.25%-9.89%-10.26%-11.32%-12.29%-13.93%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
299.000.00M-0.01M-0.02M-0.03M-0.02M-0.01M0.01M0.02M0.01M0.01M-0.03M-0.09M-0.15M-0.06M592.00-0.04M-0.04M-0.15M-0.25M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M-0.01M-0.02M-0.03M-0.03M-0.03M-0.03M-0.01M-0.01M-0.00M-0.02M-0.05M-0.10M-0.16M-0.06M-0.03M-0.11M-0.17M-0.20M-0.29M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.04M0.01M-0.00M-0.02M-0.03M-0.02M-0.02M-0.01M-0.00M-0.01M-0.02M-0.06M-0.10M-0.16M-0.08M-0.05M-0.14M-0.19M-0.23M-0.30M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-0.00M-0.00M-0.01M-0.01M-0.00M0.00M-0.00M0.01M0.01M-0.00M-0.01M-0.03M-0.05M-0.06M0.08M0.03M-0.09M-0.06M-0.03M-0.07M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.00M-0.01M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M-0.02M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-0.00M-0.02M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.00M-0.00M-0.39M-0.12M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.00M-0.02M-0.40M-0.13M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
Return on Equity [ROE] (QoQ)ROE (QoQ)
-0.00M-0.01M-0.38M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.14M0.71M0.52M-0.02M-0.03M-0.09M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
4.60M3.92M6.04M3.66M3.02M5.32M6.52M12.09M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
3.62M2.32M8.24M2.88M2.41M1.94M3.81M3.58M4.72M4.54M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.57M0.16M0.57M-0.01M-0.00M-0.03M0.02M-0.01M-0.07M
Revenue Growth (1y)
233.80%
Revenue Growth (3y)
144.17%447.88%256.51%
Revenue Growth (5y)
59.85%153.62%102.24%93.41%77.29%
Revenue (QoQ)
-67.76%-10.56%-54.56%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
1,190.11%286.83%453.92%-82.25%-66.67%-66.67%-62.51%-53.71%0.01%-0.51%0.00%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
-29.54%-21.38%43.71%36.06%-6.01%1.96%8.66%49.29%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
26.48%-22.75%-31.30%29.43%-52.27%-36.74%-25.42%-30.51%2.16%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-197.17%1,715.27%-75.35%0.00%-11.10%-19.00%-53.71%0.01%0.00%0.00%0.00%-0.51%0.52%
Total Debt Growth (1y)
72.66%52.39%101.71%65.00%16.18%-16.97%52.79%-25.47%-16.03%-2.91%-3.61%1.07%8.22%3.58%-53.78%-9.16%-22.05%-21.86%
Total Debt Growth (3y)
18.98%7.10%43.76%7.52%1.82%-5.83%-12.03%-11.88%-10.86%-7.72%
Total Debt Growth (5y)
7.28%-0.11%
Total Debt (QoQ)
-17.22%22.57%23.99%21.13%9.58%0.26%-12.70%-13.43%101.65%-51.10%-1.64%0.10%100.19%-48.72%5.31%-4.19%-10.66%0.77%-9.63%-3.96%

CNBX Pharmaceuticals Growth Metrics API

Pull CNBX Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CNBX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY